LEI 9HN and *SmithKline Beecham Pharmaceuticals, Great Burgh, Epsom, Surrey KT18 5XQ1 The ability of BRL 38227 and nitrendipine to affect muscarinic agonist and histamine-stimulated [3H]-inositol phosphate accumulation in slices of bovine tracheal smooth muscle has been studied and compared with the established inhibitory effects of isoprenaline on this pathway.2 Pre-addition of BRL 38227 (5 J4M), nitrendipine (1 I1M) or isoprenaline (10 IJM) significantly inhibited the subsequent inositol phosphate response to histamine at all concentrations studied (10-1000 AM).BRL 38227 and nitrendipine also significantly inhibited the [3H]-inositol phosphate response to low (1 tiM), but not high (100 AM) concentrations of carbachol. Isoprenaline had no effect at any concentration of carbachol studied. 3 Nitrendipine (IC50 = 95 nM) and BRL 38227 (IC50 = 322 nM) caused concentration-related inhibitions of the inositol phosphate response to histamine (100 JM). Similar maximal inhibitions were caused by each agent (55-58%). Inhibitory effect of BRL 38227 was reduced in potency (ICM = 5.5 JiM), but not magnitude, in the presence of glibenclamide (O.5 JAM). 4 Time-course studies comparing the effects of BRL 38227 addition 15 min before, and 10 min after histamine challenge showed that for pre-addition a distinct (<2 min) lag occurred following histamine addition before the inhibitory effect of BRL 38227 was manifest. In contrast, when BRL 38227 was added O min after histamine, an inhibitory effect was immediately apparent. 5 Further evidence for an initial, 'protected' phase of inositol phosphate accumulation was provided by the finding that BRL 38227 pre-addition had no effect on the early (0-300 s) time-course of inositol 1,4,5-trisphosphate mass accumulation. 6 The inhibitory effect of BRL 38227, but not that of nitrendipine or isoprenaline, on histaminestimulated [3H]-inositol phosphate accumulation was completely prevented in the presence of an elevated extracellular K+ (65 mM) concentration. 7 The results demonstrate that membrane hyperpolarization, and/or blockade of voltage-operated Ca2"-channels can regulate agonist-stimulated phosphoinositide metabolism in airway smooth muscle.The possible contribution of this regulatory mechanism to the relaxant properties of these agents is discussed.